A program for real-time surveillance of SARS-CoV-2 genetics.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
30 Aug 2024
Historique:
received: 08 05 2024
accepted: 20 08 2024
medline: 31 8 2024
pubmed: 31 8 2024
entrez: 30 8 2024
Statut: epublish

Résumé

The COVID-19 pandemic brought forth an urgent need for widespread genomic surveillance for rapid detection and monitoring of emerging SARS-CoV-2 variants. It necessitated design, development, and deployment of a nationwide infrastructure designed for sequestration, consolidation, and characterization of patient samples that disseminates de-identified information to public authorities in tight turnaround times. Here, we describe our development of such an infrastructure, which sequenced 594,832 high coverage SARS-CoV-2 genomes from isolates we collected in the United States (U.S.) from March 13th 2020 to July 3rd 2023. Our sequencing protocol ('Virseq') utilizes wet and dry lab procedures to generate mutation-resistant sequencing of the entire SARS-CoV-2 genome, capturing all major lineages. We also characterize 379 clinically relevant SARS-CoV-2 multi-strain co-infections and ensure robust detection of emerging lineages via simulation. The modular infrastructure, sequencing, and analysis capabilities we describe support the U.S. Centers for Disease Control and Prevention national surveillance program and serve as a model for rapid response to emerging pandemics at a national scale.

Identifiants

pubmed: 39215120
doi: 10.1038/s41598-024-70697-9
pii: 10.1038/s41598-024-70697-9
pmc: PMC11364650
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

20249

Informations de copyright

© 2024. The Author(s).

Références

Lancet. 2020 Feb 22;395(10224):565-574
pubmed: 32007145
mSystems. 2021 Aug 31;6(4):e0039221
pubmed: 34342536
Virus Evol. 2018 Jan 08;4(1):vex042
pubmed: 29340210
Int J Infect Dis. 2022 Sep;122:212-214
pubmed: 35605952
Sci Rep. 2022 Nov 8;12(1):18968
pubmed: 36347878
Virus Evol. 2021 Jul 30;7(2):veab064
pubmed: 34527285
J Clin Invest. 2020 Apr 1;130(4):1545-1548
pubmed: 32167489
Nat Rev Microbiol. 2023 Jun;21(6):361-379
pubmed: 37020110
Bioinformatics. 2018 Sep 15;34(18):3094-3100
pubmed: 29750242
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
Comput Struct Biotechnol J. 2022;20:1389-1401
pubmed: 35342534
J Open Source Softw. 2021;6(57):
pubmed: 34189396
Genome Biol. 2022 Nov 8;23(1):236
pubmed: 36348471
Nat Rev Microbiol. 2023 Mar;21(3):147-161
pubmed: 36460930
Nat Rev Genet. 2021 Dec;22(12):757-773
pubmed: 34535792
Virus Res. 2020 Nov;289:198147
pubmed: 32866537
Comput Struct Biotechnol J. 2022;20:4015-4024
pubmed: 35915661
Clin Microbiol Infect. 2022 Nov;28(11):1503.e5-1503.e8
pubmed: 35792280
J Comput Biol. 2015 Jun;22(6):498-509
pubmed: 25658651
Heliyon. 2023 Feb;9(2):e13103
pubmed: 36712916
Life (Basel). 2022 Jan 04;12(1):
pubmed: 35054462
Sci Total Environ. 2020 Oct 15;739:139076
pubmed: 32758929
Nucleic Acids Res. 2022 Jan 7;50(D1):D20-D26
pubmed: 34850941
Viruses. 2022 Apr 28;14(5):
pubmed: 35632661
Nat Biotechnol. 2019 Oct;37(10):1155-1162
pubmed: 31406327
Bioinformatics. 2018 Dec 1;34(23):4121-4123
pubmed: 29790939
Microorganisms. 2021 Feb 02;9(2):
pubmed: 33540596
Microbiol Spectr. 2022 Aug 31;10(4):e0124722
pubmed: 35856710
Bioinformatics. 2011 Jun 15;27(12):1691-2
pubmed: 21493652
EClinicalMedicine. 2021 Jun;36:100902
pubmed: 34056568
Front Public Health. 2022 Jan 04;9:818401
pubmed: 35059385
Emerg Infect Dis. 2022 Jul;28(7):1442-1445
pubmed: 35551714
Nat Biotechnol. 2011 Jan;29(1):24-6
pubmed: 21221095
Genome Med. 2023 Jul 24;15(1):57
pubmed: 37488638
J Med Virol. 2022 Aug;94(8):3506-3508
pubmed: 35419806
Int J Mol Sci. 2022 Nov 14;23(22):
pubmed: 36430535
Virus Res. 2021 Apr 15;296:198345
pubmed: 33631222
Science. 2021 Apr 16;372(6539):
pubmed: 33688063
Glob Chall. 2017 Jan 10;1(1):33-46
pubmed: 31565258
Nat Genet. 2021 Jun;53(6):809-816
pubmed: 33972780
Nat Commun. 2022 Feb 3;13(1):635
pubmed: 35115523
PLoS One. 2020 Sep 18;15(9):e0239403
pubmed: 32946527
JAMA. 2022 Jul 5;328(1):11
pubmed: 35788811
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
Genomics Proteomics Bioinformatics. 2015 Oct;13(5):278-89
pubmed: 26542840
Genome Biol. 2019 Jan 8;20(1):8
pubmed: 30621750
Methods Mol Biol. 2020;2102:61-113
pubmed: 31989550
Nature. 2022 Sep;609(7925):101-108
pubmed: 35798029
Viruses. 2023 Apr 14;15(4):
pubmed: 37112949
Nat Commun. 2022 May 18;13(1):2745
pubmed: 35585202
MMWR Morb Mortal Wkly Rep. 2022 Nov 04;71(44):1418-1424
pubmed: 36327157
BMC Genomics. 2022 Feb 11;23(1):121
pubmed: 35148677
Nature. 2020 Mar;579(7798):265-269
pubmed: 32015508
Front Public Health. 2021 May 31;9:679012
pubmed: 34136460

Auteurs

Hayden N Brochu (HN)

Labcorp Center for Excellence in Data Science, AI and Bioinformatics, Burlington, NC, 27215, USA.

Kuncheng Song (K)

Labcorp Center for Excellence in Data Science, AI and Bioinformatics, Burlington, NC, 27215, USA.

Qimin Zhang (Q)

Labcorp Center for Excellence in Data Science, AI and Bioinformatics, Burlington, NC, 27215, USA.

Qiandong Zeng (Q)

Labcorp Center for Excellence in Data Science, AI and Bioinformatics, Burlington, NC, 27215, USA.

Adib Shafi (A)

Labcorp Center for Excellence in Data Science, AI and Bioinformatics, Burlington, NC, 27215, USA.

Matthew Robinson (M)

Labcorp Center for Excellence in Data Science, AI and Bioinformatics, Burlington, NC, 27215, USA.

Jake Humphrey (J)

Labcorp Center for Excellence in Data Science, AI and Bioinformatics, Burlington, NC, 27215, USA.

Bobbi Croy (B)

Labcorp Information Technology, Burlington, NC, 27215, USA.

Lydia Peavy (L)

Labcorp Research and Development, Burlington, NC, 27215, USA.

Minoli Perera (M)

Labcorp Research and Development, Burlington, NC, 27215, USA.

Scott Parker (S)

Labcorp Research and Development, Burlington, NC, 27215, USA.

John Pruitt (J)

Labcorp Research and Development, Burlington, NC, 27215, USA.

Jason Munroe (J)

Labcorp Consumer Genetics Department, Burlington, NC, 27215, USA.

Rama Ghatti (R)

Labcorp-Sequenom, San Diego, CA, 92121, USA.

Thomas J Urban (TJ)

Labcorp Research and Development, Burlington, NC, 27215, USA.

Ayla B Harris (AB)

Labcorp Research and Development, Burlington, NC, 27215, USA.

David Alfego (D)

Labcorp Center for Excellence in Data Science, AI and Bioinformatics, Burlington, NC, 27215, USA.

Brian Norvell (B)

Labcorp Research and Development, Burlington, NC, 27215, USA.

Michael Levandoski (M)

Labcorp Research and Development, Burlington, NC, 27215, USA.
Q2 Solutions, an IQVIA Business, Durham, NC, 27703, USA.

Brian Krueger (B)

Labcorp Research and Development, Burlington, NC, 27215, USA.
BaseX Scientific, LLC, Chapel Hill, NC, 27516, USA.

Jonathan D Williams (JD)

Labcorp Research and Development, Burlington, NC, 27215, USA.

Deborah Boles (D)

Labcorp Research and Development, Burlington, NC, 27215, USA.

Melinda B Nye (MB)

Labcorp Center for Esoteric Testing, Burlington, NC, 27215, USA.

Suzanne E Dale (SE)

Labcorp Center for Esoteric Testing, Burlington, NC, 27215, USA.

Michael Sapeta (M)

Labcorp Center for Esoteric Testing, Burlington, NC, 27215, USA.

Christos J Petropoulos (CJ)

Labcorp-Monogram Biosciences, South San Francisco, CA, 94080, USA.

Jonathan Meltzer (J)

Labcorp Center for Esoteric Testing, Burlington, NC, 27215, USA.

Marcia Eisenberg (M)

Labcorp Research and Development, Burlington, NC, 27215, USA.

Oren Cohen (O)

Labcorp Drug Development, Burlington, NC, 27215, USA.
Fortrea Inc, Durham, NC, 27703, USA.

Stanley Letovsky (S)

Labcorp Center for Excellence in Data Science, AI and Bioinformatics, Burlington, NC, 27215, USA.

Lakshmanan K Iyer (LK)

Labcorp Center for Excellence in Data Science, AI and Bioinformatics, Burlington, NC, 27215, USA. iyerl@labcorp.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH